Stocksigma LogoStocksigma Logo

Shree Ganesh Biotech (India) Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh)

■ Revenue: 16.0 (-79.2% YoY | -88.8% QoQ) ■ EBITDA: -40.4 (-1.9% YoY | +54.8% QoQ) ■ EBITDA Margin (%): -252 (-20058 bps YoY | -18971 bps QoQ) ■ PAT: -8.1

Shree Ganesh Biotech (India) Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh)

Shree Ganesh Biotech (India) Ltd · Outcome · 02 Nov 2026, 10:53 pm

Shree Ganesh Biotech (India) Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh) ■ Revenue: 16.0 (-79.2% YoY | -88.8% QoQ) ■ EBITDA: -40.4 (-1.9% YoY | +54.8% QoQ) ■ EBITDA Margin (%): -252 (-20058 bps YoY | -18971 bps QoQ) ■ PAT: -8.1 (Profit to Loss YoY | +85.9% QoQ) ■ EPS (INR): 0.00 (Loss to Profit QoQ)

Original exchange filing (PDF)

More announcements from Shree Ganesh Biotech (India) Ltd

All Shree Ganesh Biotech (India) Ltd announcements